Navigation Links
Mesa Labs Reports Record Year End Sales and Earnings
Date:5/19/2008

net sales of 10 percent. The decline in the quarter was due to a one time adjustment of the income taxes that occurred in the fourth quarter of last fiscal year and was attributable to favorable income tax treatment on assets acquired in the Raven acquisition during fiscal 2007. When compared on a quarterly basis, income tax expense in the fourth quarter of fiscal 2008 was 40 percent of income before taxes compared to 21 percent in the comparable period one year ago. If adjusted to the total year fiscal 2008 tax rate, net income for the fourth quarter of fiscal 2007 would have been lower by approximately $280,000 to $1,158,000. Using this adjusted fiscal 2007 net income for comparison, fiscal 2008 fourth quarter net income of $1,195,000 would have increased three percent compared to the $1,158,000 of adjusted net income in the fourth quarter of fiscal 2007.

"The fourth quarter of Fiscal 2008 was an excellent finish for a year in which we posted solid growth at Mesa," said John J. Sullivan, President and Chief Operating Officer. "Going into the quarter we had a challenging goal to meet to be able to exceed the exceptional fourth quarter that we had last year, but the Mesa team pulled together and we posted 10 percent sales growth for the quarter. With record sales and operating profits for both the quarter and the year, Mesa's businesses all have very good momentum."

"We are very excited about the prospects for the new fiscal year," continued John Sullivan. "We have recently introduced the most significant advancement in our data logger technology since the inception of the product line in the mid 1980's. The new DataTrace RF System provides real time data, an expanded temperature range and greatly increased battery lifetime. These new features are important for our data logger customers in all of our markets. This new product has been well received by our early adopters and we expect the DataTrace RF to bolster our growth in the high performance data l
'/>"/>

SOURCE Mesa Laboratories, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. BMP Sunstone Reports First Quarter 2008 Financial Results
2. Huiheng Medical, Inc. Reports Record Financial Results for Fiscal Year 2007 and Financial Results for Q1 2008
3. CEL-SCI Corporation Reports Second Quarter 2008 Financial Results
4. Shengtai Pharmaceutical, Inc. Reports Third Quarter Results of Fiscal Year 2008
5. China Yingxia International, Inc. Reports First Quarter 2008 Results
6. Digital Power Reports Financial Results for the First Quarter Ended March 31, 2008
7. Genesis Pharmaceuticals Reports Results for the Third Quarter of Fiscal Year 2008
8. Pharmasset Reports Financial Results for Quarter Ended March 31, 2008
9. Nephros Reports 2008 First Quarter Financial Results
10. PreMD Reports First Quarter Results
11. Lifeway Foods Reports Record 1st Quarter 2008 Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...ce"reform"isamoraloutrage ,, WASHINGTON,Nov.2...ovedforwardtobeginthedebateontheirhealthcare"refor...nggrassrootssenioradvocacygroup,iscallingonallofAm...ivecutstoMedicare.RetireSafePresidentThairPhillips...axes,abortion,andimmigration,whilethesimple,uncomp...
(Date:11/23/2009)...,, WHAT: ,, TheBerylInstitute, theresearc...sleadinghealthcareexclusivecallcenter,issponsoring...ygenerationwithapositivecustomerserviceexperience....binarwillsupplementHowe,sJune2009whitepaper,"Custo...sseshowconsumerswillultimatelytransformhealthcared...
(Date:11/23/2009)...re/--CortivaInstituteTucsonwillhostanIntroductiont...theschool,s6390EastBroadwayBlvd.location,whichwill...icebasicmassagestrokes. ,, "Massagetherapyisagr...longwithit,"saidJoannMcMaster,presidentofCortivaIn...or,s2009-2010OccupationalOutlookHandbookstatesthat...
(Date:11/23/2009)...swire/--InasurveyofNewJerseyandPhiladelphiaregiona...2percentdonotbelieveanewhealthcarebillwouldlikelyr...esultsofthelatestsurveyconductedbytheAlloySilverst...ppedthelistat85percentasthebiggestnationalissue.Th...tocompaniesfromallpartsofNewJerseyandSoutheasternP...
(Date:11/23/2009)...nce Writings at Stevens Institute of Technology wi...t Wright, journalist and founder, Bloggingheads.tv...he Babbio Center for Technology Management, Room 1...he media., In his new book "The Evolution of God...ned for his popular works on evolutionary psycholo...
Breaking Medicine News(10 mins):Health News:RetireSafe Calls on Seniors to Grab their Bullhorns to Save Medicare from Rationed Care 2Health News:Tips to Improve Healthcare Customer Service Across All Generations 2Health News:Cortiva Institute To Host Workshop, Hands-On Opportunity for Prospective Students 2
...ncy-related blood pressure condition can pose seri...RIDAY, Oct. 17 (HealthDay News) -- Pregnant with h...minal pain and headaches until her symptoms worsen...is one of hundreds of women whose brush with preec...
...cademy of Ophthalmology hosts event October 24 ben... Sullivan headlines event, OKLAHOMA CITY, Oct. 17...e second annual "Eye Ball," benefiting the,Juvenil...Gary Story of Oklahoma City are the honorary chair...
...t. 17 American Well today announced that CEO,Roy ...product management;,and Michael Stollar, vice pres...s Blue Shield of Hawaii (HMSA), will provide a liv...t 10:00,a.m. PDT on October 23, 2008 at San Franci...
..., Calif., Oct. 17 Wyle is a key partner in,the wi...Center contract to,provide occupational health ser...year contract, valued at up to $24 million, is due...ealth physics,and respiratory protection., "We ar...
...sunderstand written screening tools, but ,talking,...17 (HealthDay News) -- Many patients misunderstand...answer before physical exams, a finding that calls...he American College of Surgeons, found that lower-...
...TON, Oct. 17 After a destructive,hurricane season... for,disasters, the American Public Health Associa...d ones are prepared for winter storms and any othe...make sure their emergency preparedness kits are st...
Other Medicine News:Health News:Research May Help Predict Preeclampsia 2Health News:Research May Help Predict Preeclampsia 3Health News:Research May Help Predict Preeclampsia 4Health News:Second Annual 'Eye Ball' Fights Juvenile Diabetes, Says Oklahoma Academy of Ophthalmology 2Health News:Second Annual 'Eye Ball' Fights Juvenile Diabetes, Says Oklahoma Academy of Ophthalmology 3Health News:American Well Systems CEO Roy Schoenberg to Present Live Public Demo of First Online Care Service at Health 2.0 Conference 2Health News:Wyle Key Part of Winning Team for Marshall Space Flight Center Occupational Health Services Contract 2Health News:Doctors Often Overestimate Patients' Health Literacy 2Health News:Check Your Emergency Preparedness Kits When You Set Your Clocks, Says American Public Health Association Campaign 2
(Date:11/23/2009)...re-FirstCall/--WoundManagementTechnologies,Inc.,(O...ialtymedicalproducts,announcedthatithasfileditQ320...gementbusinessupdatetoillustratethedevelopmentsdur...d33.5%to$102,926vs.Q32008salesof$77,084. , Sh...s.Q32008shareholderequityof$(321,257) , Total...
(Date:11/23/2009)...tCall/--CordBloodAmerica,Inc.(OTCBulletinBoard:CBA...y( http://www.cordblood-america.com )focusedonbrin...nsurancepolicy,tofamiliesnationwideandinternationa...thCEOandco-founderMatthewSchisslerisnowavailable. ...2875811 . ,, Intheinterview,Mr.Schisslerupdates...
(Date:11/23/2009)...-FirstCall/--RaptorPharmaceuticalCorp.("Raptor"ort...tationofclinicaltrialdataonNGX426,theCompany,soral...gonist,atthe12thInternationalConferenceontheMechan...-21inSanFrancisco.TheresultsofthestudyledbyMarkWal...nterforPainMedicineoftheUniversityofCaliforniaatSa...
Breaking Medicine Technology:Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 2Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 3Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 4Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 5Raptor Pharmaceutical Corp. Announces Positive Data on NGX426 in the Potential Treatment of Neuropathic Pain 2Raptor Pharmaceutical Corp. Announces Positive Data on NGX426 in the Potential Treatment of Neuropathic Pain 3Raptor Pharmaceutical Corp. Announces Positive Data on NGX426 in the Potential Treatment of Neuropathic Pain 4Raptor Pharmaceutical Corp. Announces Positive Data on NGX426 in the Potential Treatment of Neuropathic Pain 5Cytel Signs Cooperative Research And Development Agreement With FDA Center for Devices and Radiological Health 28CDRH 29 4629 1Cytel Signs Cooperative Research And Development Agreement With FDA Center for Devices and Radiological Health 28CDRH 29 4629 2Cytel Signs Cooperative Research And Development Agreement With FDA Center for Devices and Radiological Health 28CDRH 29 4629 3CoAxia Inc Announces 2421 5M Series D Financing 4628 1CoAxia Inc Announces 2421 5M Series D Financing 4628 2CoAxia Inc Announces 2421 5M Series D Financing 4628 3Lilly Declares Third Quarter Dividend 49687 1
...e II study extension shows 68-73% of patients with... three years of treatment with oral FTY720,- New d...rain lesions - the injury caused by MS - thr...ating disease causing progressive disability, affe...g many young adults - FTY720 regulatory filings p...
... MEK inhibitor, RDEA119, demonstrates potential fo...nary Phase 1 results -, - Next generation MEK inh... half of 2008 -, SAN DIE...EA ) today announced that data was presented demon...okinetic profile of the Company,s,mitogen-activate...
Other Medicine Technology:FTY720, a novel oral therapy in development for MS, shows sustained benefits for the majority of patients after three years of treatment 2FTY720, a novel oral therapy in development for MS, shows sustained benefits for the majority of patients after three years of treatment 3FTY720, a novel oral therapy in development for MS, shows sustained benefits for the majority of patients after three years of treatment 4FTY720, a novel oral therapy in development for MS, shows sustained benefits for the majority of patients after three years of treatment 5FTY720, a novel oral therapy in development for MS, shows sustained benefits for the majority of patients after three years of treatment 6Ardea Biosciences Presents Data Demonstrating Favorable Pharmacokinetics and Efficacy for Mitogen-Activated ERK Kinase (MEK) Inhibitors 2Ardea Biosciences Presents Data Demonstrating Favorable Pharmacokinetics and Efficacy for Mitogen-Activated ERK Kinase (MEK) Inhibitors 3Ardea Biosciences Presents Data Demonstrating Favorable Pharmacokinetics and Efficacy for Mitogen-Activated ERK Kinase (MEK) Inhibitors 4
...s a second generation nucleic acid amplification t...ive detection and differentiation of rRNA from CT ...ven technologies including target capture (TC), Tr...Kinetic Assay (DKA). This is the same family of te...
One-Step Gonorrhea Antigen Test
...on Information System) is an open architecture sys...tform designed to communicate and manage patient d...in various ways, as NAVIS can connect not only to ...halmic diagnostic equipment of other manufacturers...
...state technology, this laser emit true continuous-...d-state technology offers unsurpassed reliability,...lity, compact size allows easy transportation betw...tine laser maintenance. The EasyFit Adapter conver...
Medicine Products: